The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Increased Susceptibility to Pulmonary Hypertension in Heterozygous BMPR2-Mutant Mice
Open accessAbstract
Background— Bone morphogenetic protein receptor-2 (BMPR2)–heterozygous, mutant ( BMPR2 +/− ) mice have a genetic trait similar to that of certain patients with idiopathic pulmonary arterial hypertension (IPAH). To understand the role of BMPR2 in the development of IPAH, we examined the phenotype of BMPR2 +/− mice and their response to inflammatory stress. Methods and Results— BMPR2 +/− mice were found to have the same life span, right ventricular systolic pressure (RVSP), and lung histology as those of wild-type mice under unstressed conditions. However, when treated with recombinant adenovirus expressing 5-lipoxygenase (Ad5LO), BMPR2 +/− mice exhibited significantly higher RVSP than wild-type mice. The increase of RVSP occurred in the first 2 weeks after Ad5LO delivery. Modest but significant muscularization of distal pulmonary arterioles appeared in BMPR2 +/− mice 4 weeks after Ad5LO treatment. Measurement of urinary metabolites of vasoactive molecules showed that cysteinyl leukotrienes, prostacyclin metabolites, and PGE 2 were all increased to a similar degree in both BMPR2 +/− and wild-type mice during 5LO transgene expression, whereas urinary endothelin-1 remained undetectable. Urinary thromboxane A 2 metabolites, in contrast, were significantly higher in BMPR2 +/− than in wild-type mice and paralleled the increase in RVSP. Platelet activation markers, serotonin, and soluble P-selectin showed a trend toward higher concentrations in BMPR2 +/− than wild-type mice. Cell culture studies found that BMP treatment reduced interleukin-1β–stimulated thromboxane A 2 production in the pulmonary epithelial cell line A549. Conclusions— BMPR2 +/− mice do not develop pulmonary hypertension spontaneously; however, under inflammatory stress, they are more susceptible to an increase in RVSP, thromboxane A 2 production, and vascular remodeling than wild-type mice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pulmonary hypertension and inflammation
Tuder, R. M., & Voelkel, N. F. (1998) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(98)90020-8 · Cited by 128
Cited by
Molecular pathogenesis of pulmonary arterial hypertension
Rabinovitch, M. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33452 · Cited by 880
Cellular and Molecular Basis of Pulmonary Arterial Hypertension
Morrell, N. W., Adnot, S., Archer, S. L., Dupuis, J., Lloyd Jones, P., MacLean, M. R., McMurtry, I. F., Stenmark, K. R., Thistlethwaite, P. A., Weissmann, N., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.018 · Cited by 819
Stenmark, K. R., Meyrick, B., Galie, N., Mooi, W. J., & McMurtry, I. F. (2009) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00217.2009 · Cited by 774
Molecular pathogenesis of pulmonary arterial hypertension
Rabinovitch, M. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60658 · Cited by 653
Pathology of Pulmonary Hypertension
Tuder, R. M., Stacher, E., Robinson, J., Kumar, R., & Graham, B. B. (2013) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2013.08.009 · Cited by 439
Metadata
- Authors
- Song, Y., Jones, J. E., Beppu, H., Keaney, J. F., Loscalzo, J., & Zhang, Y.-Y.
- Venue
- Circulation
- Published
- 2005-07-26
- Volume
- 112
- Issue
- 4
- Pages
- 553-562
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1997617706
- Cited by
- 211
- References
- 1
- FWCI
- 9.13
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Increased Susceptibility to Pulmonary Hypertension in Heterozygous BMPR2-Mutant Mice. https://app.cochat.ai/papers/10.1161/circulationaha.104.492488
- The paper
- Song, Y., Jones, J. E., Beppu, H., Keaney, J. F., Loscalzo, J., & Zhang, Y.-Y. (2005). Increased Susceptibility to Pulmonary Hypertension in Heterozygous BMPR2-Mutant Mice. Circulation. https://doi.org/10.1161/circulationaha.104.492488
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.